Influence of beta-blocker use on percentage of target heart rate exercise prescription

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 10, Issue 4, 2003, Pages 296-301

  Wonisch, Manfred ^a   Hofmann, Peter ^b   Fruhwald, Friedrich M ^a   Kraxner, Wilfried ^a   Hödl, Ronald ^a   Pokan, Rochus ^c   Klein, Werner ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aerobic threshold; Aerobic training; Anaerobic threshold; Bisoprolol; Ratings of perceived exertion; Respiratory equivalent

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; PLACEBO;

ACCURACY; ADULT; AEROBIC METABOLISM; ANAEROBIC THRESHOLD; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; EXERCISE; EXERCISE TEST; EXHAUSTION; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; METHODOLOGY; NORMAL HUMAN; OXYGEN CONSUMPTION; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; TASK PERFORMANCE; WORKLOAD;

EID: 0242491063     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/00149831-200308000-00013     Document Type: Article

References (36)

1. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. Philadelphia, PA: Lippincott Williams & Wilkins; 2000. pp. 145-147 and 165-199.
2. Braunwald E, Zipes Dp, Libby P. Heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia, PA: W.B. Saunders Company; 2001. pp. 1406-1421.
3. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards: a statement for Healthcare professionals from the American Heart Association. Circulation 2001; 104:1614-1740.
4. American College of Sports Medicine. Position stand on the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30:975-991.
5. Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B. et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans. Circulation 1996; 94:857-862.
6. Brooks GA, Fahey TD, White TP, Baldwin KM. Exercise physiology: human bioenergetics and its applications. 3rd Ed. Mayfield Publishing Company, California; 2000. pp. 639-682.
7. Shephard RJ, Miller HS. Exercise and the heart in health and disease. New York: Marcel Dekker, Inc.; 1999. pp. 275-294.
8. Foster C, Cadwell K, Crenshaw B, Dehart-Beverley M, Hatcher S, Karlsdottier AE, et al. Physical activity and exercise training prescriptions for patients. Cardiol Clin 2001; 19:447-457.
9. max target heart rate is dependent on heart rate performance curve deflection. Med Sci Sports Exerc 2001; 33:1726-1731.
10. max target HR is dependent on HR-performance curve deflection in cardiac patients. Med Sci Sports Exerc 2001; 33:S27.
11. max adequate? Med Sci Sports Exerc 1999; 31:1342-1345.
12. 2 Borg GA. Psychological bases of perceived exertion. Med Sci Sports Exerc 1982; 14:377-381.
13. Aunola S, Rusko H. Reproducibility of aerobic and anaerobic thresholds in 20-50 year old men. Eur J Appl Physiol 1984; 53:260-266.
14. Skinner JS, Mclellan TH. The transition from aerobic to anaerobic metabolism. Res Quart Exerc Sport 1980; 51:234-248.
15. Pokan R, Hofmann P, Von Duvillard SP, Beaufort F, Smekal G, Gasser R, et al. The heart rate performance curve and left ventricular function during exercise in patients after myocardial infarction. Med Sci Sports Exerc 1998; 30:1475-1480.
16. Simonton CA, Higginbotham MB, Cobb FR. The ventilatory threshold: quantitative analysis of reproducibility and relation to arterial lactate concentration in normal subjects and in patients with chronic congestive heart failure. Am J Cardiol 1988; 62:100-107.
17. Chick TW, Halperin AK, Gacek EM. The effect of anti-hypertensive medications on exercise performance: a review. Med Sci Sports Exerc 1988; 20:447-454.
18. Brion R, Carre F, Verdier J-C, Poncelet P, Douard H, Page E, et al. Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients with regular physical activity. J Cardiovasc Pharmacol 2000; 35:78-83.
19. Wittke R, Kemmler W. Effects of metoprolol (M CR/Zok) on the physical endurance performance of patients with arterial hypertension. Clin Drug Invest 1999; 17:255-263.
20. Sklar J, Johnston GD, Overlie P, Gerber JG, Brammell HL, Gal J, Nies AS. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Circulation 1982; 65:894-899.
21. Reybrouck T, Amery A, Billiet L. Haemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol 1977; 42:133-138.
22. Frisk-Homberg M, Juhlin-Dannfelt A, Astrom H. Haemodynamic and metabolic responses to prolonged exercise after chronic β1-adrenoceptor blockade in hypertensive man. Clin Physiol 1985; 5:231-242.
23. Vanhees L, Defoor JGM, Schepers D, Lijnen P, Peeters BYM, Lacante PHL, Fagard RH. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men. J Hypertens 2000; 18:35-43.
24. Poulsen SH, Jensen SE, Egstrup K. Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction. Am Heart J 2000; 140: 6-11.
25. Gordon NF, Van Rensburg JP, Van Den Heever DP, Kalliatiakis NB, Myburgh DP. Effect of dual β-blockade and calcium antagonism on endurance performance. Med Sci Sports Exerc 1987; 19:1-6.
26. Gordon NF, Duncan JJ. Effect of beta-blockers on exercise physiology: implications for exercise training. Med Sci Sports Exerc 1991; 23:668-676.
27. Froelicher V, Sullivan M, Myers J, Jensen D. Can patients with coronary artery disease receiving beta-blockers obtain a training effect? Am J Cardiol 1985; 55:155d-161d.
28. Mcleod A, Kraus W, Williams RS. Effects of beta1-selective and non-selective beta-adrenoceptor blockade during exercise conditioning in healthy adults. Am J Cardiol 1984; 53:1656-1661.
29. Albert CM, Mittleman MA, Chae CU, Lee I-M, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343:1355-1361.
30. Pokan R, Hofmann P, Lehmann M, Leitner H, Eber B, Gasser R, et al. Heart rate deflection related to lactate performance curve and plasma catecholamine response during incremental cycle ergometer exercise. Eur J Appl Physiol 1995; 70:175-179.
31. Tegtbur U, Meyer H, Machold H, Busse MW. Exercise recommendation and catecholamines in patients with coronary artery disease. Z Kardiol 2002; 91:927-936.
32. Boucher CA, Anderson MD, Schneider MS, Murphy JH, Okada RD, Kanaarek DJ. Left ventricular function before and after reaching the anaerobic threshold. Chest 1985; 87:145-150.
33. Koike A, Itoh H, Taniguchi K, Hiroe M. Detecting abnormalities in left ventricular function during exercise by respiratory measurement. Circulation 1989; 80:1727-1746.
34. Haeusler G. Pharmacology of beta-blockers: classical aspects and recent developments. J Cardiovasc Pharmacol 1990; 16(Suppl. 5): S1-S9.
35. Chwalbinska-Moneta J, Kaciuba-Usciuba H, Krysztofiak H, Ziemba A, Krzeminski K, Kruk B et al. Relationship between EMG, blood lactate, and plasma catecholamine thresholds during graded exercise in men. J Physiol Pharmacol 1998; 49:433-441.
36. VanBaak MA, Koene FM, Verstappen FT. Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects. Br J Clin Pharmacol 1988; 25:169-177.